{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:33:40Z","timestamp":1778618020034,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IN-168\/3-1"],"award-info":[{"award-number":["IN-168\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GET UP Project Code H61J08000200001"],"award-info":[{"award-number":["GET UP Project Code H61J08000200001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00406-016-0728-z","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T06:18:59Z","timestamp":1472624339000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors"],"prefix":"10.1007","volume":"268","author":[{"given":"Alessia","family":"Luoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragos","family":"Inta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"728_CR1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","volume":"60","author":"JA Lieberman","year":"2008","unstructured":"Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG (2008) Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 60:358\u2013403","journal-title":"Pharmacol Rev"},{"key":"728_CR2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neubiorev.2010.10.005","volume":"35","author":"DT Balu","year":"2011","unstructured":"Balu DT, Coyle JT (2011) Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev 35:848\u2013870","journal-title":"Neurosci Biobehav Rev"},{"key":"728_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2009.06.001","volume":"124","author":"R Molteni","year":"2009","unstructured":"Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA (2009) Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 124:74\u201385","journal-title":"Pharmacol Ther"},{"key":"728_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","volume":"128","author":"JC Neill","year":"2010","unstructured":"Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on nmda receptor antagonism. Pharmacol Ther 128:419\u2013432","journal-title":"Pharmacol Ther"},{"key":"728_CR5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","volume":"32","author":"V Bubenikova-Valesova","year":"2008","unstructured":"Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C (2008) Models of schizophrenia in humans and animals based on inhibition of nmda receptors. Neurosci Biobehav Rev 32:1014\u20131023","journal-title":"Neurosci Biobehav Rev"},{"key":"728_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.euroneuro.2008.12.002","volume":"19","author":"TM Bois du","year":"2009","unstructured":"du Bois TM, Deng C, Han M, Newell KA, Huang XF (2009) Excitatory and inhibitory neurotransmission is chronically altered following perinatal nmda receptor blockade. Eur Neuropsychopharmacol 19:256\u2013265","journal-title":"Eur Neuropsychopharmacol"},{"key":"728_CR7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm1478","volume":"12","author":"DA Lewis","year":"2006","unstructured":"Lewis DA, Gonzalez-Burgos G (2006) Pathophysiologically based treatment interventions in schizophrenia. Nat Med 12:1016\u20131022","journal-title":"Nat Med"},{"key":"728_CR8","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.63.10.1372","volume":"63","author":"DA Lewis","year":"2006","unstructured":"Lewis DA, Moghaddam B (2006) Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63:1372\u20131376","journal-title":"Arch Neurol"},{"key":"728_CR9","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","volume":"27","author":"H Homayoun","year":"2007","unstructured":"Homayoun H, Moghaddam B (2007) Nmda receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496\u201311500","journal-title":"J Neurosci"},{"key":"728_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","volume":"35","author":"DA Lewis","year":"2012","unstructured":"Lewis DA, Curley AA, Glausier JR, Volk DW (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35:57\u201367","journal-title":"Trends Neurosci"},{"key":"728_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37:4\u201315","journal-title":"Neuropsychopharmacology"},{"key":"728_CR12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295\u2013322","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"728_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","volume":"60","author":"F Nicoletti","year":"2011","unstructured":"Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60:1017\u20131041","journal-title":"Neuropharmacology"},{"key":"728_CR14","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","volume":"21","author":"G Mannaioni","year":"2001","unstructured":"Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ (2001) Metabotropic glutamate receptors 1 and 5 differentially regulate ca1 pyramidal cell function. J Neurosci 21:5925\u20135934","journal-title":"J Neurosci"},{"key":"728_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","volume":"106","author":"A Pisani","year":"2001","unstructured":"Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P (2001) Metabotropic glutamate receptor 5 mediates the potentiation of n-methyl-d-aspartate responses in medium spiny striatal neurons. Neuroscience 106:579\u2013587","journal-title":"Neuroscience"},{"key":"728_CR16","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M705661200","volume":"283","author":"J Perroy","year":"2008","unstructured":"Perroy J, Raynaud F, Homburger V, Rousset MC, Telley L, Bockaert J, Fagni L (2008) Direct interaction enables cross-talk between ionotropic and group i metabotropic glutamate receptors. J Biol Chem 283:6799\u20136805","journal-title":"J Biol Chem"},{"key":"728_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.mp.4001404","volume":"9","author":"SA Brody","year":"2004","unstructured":"Brody SA, Dulawa SC, Conquet F, Geyer MA (2004) Assessment of a prepulse inhibition deficit in a mutant mouse lacking mglu5 receptors. Mol Psychiatry 9:35\u201341","journal-title":"Mol Psychiatry"},{"key":"728_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-003-1635-3","volume":"172","author":"SA Brody","year":"2004","unstructured":"Brody SA, Conquet F, Geyer MA (2004) Effect of antipsychotic treatment on the prepulse inhibition deficit of mglur5 knockout mice. Psychopharmacology 172:187\u2013195","journal-title":"Psychopharmacology"},{"key":"728_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1461145708009085","volume":"12","author":"L Gray","year":"2009","unstructured":"Gray L, van den Buuse M, Scarr E, Dean B, Hannan AJ (2009) Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with n-methyl-d-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol 12:45\u201360","journal-title":"Int J Neuropsychopharmacol"},{"key":"728_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117\u2013154","journal-title":"Psychopharmacology"},{"key":"728_CR21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.npp.1301191","volume":"32","author":"T Lipina","year":"2007","unstructured":"Lipina T, Weiss K, Roder J (2007) The ampakine cx546 restores the prepulse inhibition and latent inhibition deficits in mglur5-deficient mice. Neuropsychopharmacology 32:745\u2013756","journal-title":"Neuropsychopharmacology"},{"key":"728_CR22","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","volume":"17","author":"YM Lu","year":"1997","unstructured":"Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder JC (1997) Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced ca1 long-term potentiation (ltp) but normal ca3 ltp. J Neurosci 17:5196\u20135205","journal-title":"J Neurosci"},{"key":"728_CR23","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1523\/JNEUROSCI.2600-08.2008","volume":"28","author":"LS Wijetunge","year":"2008","unstructured":"Wijetunge LS, Till SM, Gillingwater TH, Ingham CA, Kind PC (2008) Mglur5 regulates glutamate-dependent development of the mouse somatosensory cortex. J Neurosci 28:13028\u201313037","journal-title":"J Neurosci"},{"key":"728_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/lm.5.4.331","volume":"5","author":"Z Jia","year":"1998","unstructured":"Jia Z, Lu Y, Henderson J, Taverna F, Romano C, Abramow-Newerly W, Wojtowicz JM, Roder J (1998) Selective abolition of the nmda component of long-term potentiation in mice lacking mglur5. Learn Mem 5:331\u2013343","journal-title":"Learn Mem"},{"key":"728_CR25","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1523\/JNEUROSCI.0736-05.2005","volume":"25","author":"S Ridder","year":"2005","unstructured":"Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hortnagl H, Flor H, Henn FA, Schutz G, Gass P (2005) Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25:6243\u20136250","journal-title":"J Neurosci"},{"key":"728_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2009.07.010","volume":"34","author":"D Inta","year":"2010","unstructured":"Inta D, Monyer H, Sprengel R, Meyer-Lindenberg A, Gass P (2010) Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review. Neurosci Biobehav Rev 34:285\u2013294","journal-title":"Neurosci Biobehav Rev"},{"key":"728_CR27","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","volume":"95","author":"F Impagnatiello","year":"1998","unstructured":"Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718\u201315723","journal-title":"Proc Natl Acad Sci USA"},{"key":"728_CR28","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1073\/pnas.95.6.3221","volume":"95","author":"C Pesold","year":"1998","unstructured":"Pesold C, Impagnatiello F, Pisu MG, Uzunov DP, Costa E, Guidotti A, Caruncho HJ (1998) Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci USA 95:3221\u20133226","journal-title":"Proc Natl Acad Sci USA"},{"key":"728_CR29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.neuropharm.2011.08.010","volume":"62","author":"S Berretta","year":"2012","unstructured":"Berretta S (2012) Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 62:1584\u20131597","journal-title":"Neuropharmacology"},{"key":"728_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.mp.4002011","volume":"13","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, Mirnics K, Lewis DA (2008) Alterations in gaba-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol psychiatry 13:147\u2013161","journal-title":"Mol psychiatry"},{"key":"728_CR31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/cercor\/7.6.476","volume":"7","author":"Y Kawaguchi","year":"1997","unstructured":"Kawaguchi Y, Kubota Y (1997) Gabaergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7:476\u2013486","journal-title":"Cereb Cortex"},{"key":"728_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2011","unstructured":"Rudy B, Fishell G, Lee S, Hjerling-Leffler J (2011) Three groups of interneurons account for nearly 100% of neocortical gabaergic neurons. Dev Neurobiol 71:45\u201361","journal-title":"Dev Neurobiol"},{"key":"728_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.103.048702","volume":"306","author":"GG Kinney","year":"2003","unstructured":"Kinney GG, Burno M, Campbell UC, Hernandez LM, Rodriguez D, Bristow LJ, Conn PJ (2003) Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 306:116\u2013123","journal-title":"J Pharmacol Exp Ther"},{"key":"728_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0074-7742(03)54003-X","volume":"54","author":"SA Kotecha","year":"2003","unstructured":"Kotecha SA, MacDonald JF (2003) Signaling molecules and receptor transduction cascades that regulate nmda receptor-mediated synaptic transmission. Int Rev Neurobiol 54:51\u2013106","journal-title":"Int Rev Neurobiol"},{"key":"728_CR35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","volume":"1003","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Tsai G, Goff D (2003) Converging evidence of nmda receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 1003:318\u2013327","journal-title":"Ann N Y Acad Sci"},{"key":"728_CR36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nn0110-2","volume":"13","author":"JA Gordon","year":"2010","unstructured":"Gordon JA (2010) Testing the glutamate hypothesis of schizophrenia. Nat Neurosci 13:2\u20134","journal-title":"Nat Neurosci"},{"key":"728_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","volume":"83","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Javitt DC (2010) N-methyl-d-aspartate (nmda) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83:108\u2013121","journal-title":"Brain Res Bull"},{"key":"728_CR38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-0173(99)00044-2","volume":"31","author":"JH Meador-Woodruff","year":"2000","unstructured":"Meador-Woodruff JH, Healy DJ (2000) Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288\u2013294","journal-title":"Brain Res Brain Res Rev"},{"key":"728_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.schres.2011.01.021","volume":"128","author":"C Corti","year":"2011","unstructured":"Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F (2011) Altered levels of glutamatergic receptors and Na+\/k+ atpase-alpha1 in the prefrontal cortex of subjects with schizophrenia. Schizophr Res 128:7\u201314","journal-title":"Schizophr Res"},{"key":"728_CR40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"DA Lewis","year":"2005","unstructured":"Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312\u2013324","journal-title":"Nat Rev Neurosci"},{"key":"728_CR41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2008.11.019","volume":"65","author":"N Mellios","year":"2009","unstructured":"Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S (2009) Molecular determinants of dysregulated gabaergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65:1006\u20131014","journal-title":"Biol Psychiatry"},{"key":"728_CR42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","volume":"57","author":"A Guidotti","year":"2000","unstructured":"Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E (2000) Decrease in reelin and glutamic acid decarboxylase67 (gad67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061\u20131069","journal-title":"Arch Gen Psychiatry"},{"key":"728_CR43","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1073\/pnas.051614698","volume":"98","author":"WS Liu","year":"2001","unstructured":"Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P, Larson J, Condie BG, Guidotti A, Costa E (2001) Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci USA 98:3477\u20133482","journal-title":"Proc Natl Acad Sci USA"},{"key":"728_CR44","doi-asserted-by":"crossref","first-page":"e5505","DOI":"10.1371\/journal.pone.0005505","volume":"4","author":"CG Campo","year":"2009","unstructured":"Campo CG, Sinagra M, Verrier D, Manzoni OJ, Chavis P (2009) Reelin secreted by gabaergic neurons regulates glutamate receptor homeostasis. PLoS One 4:e5505","journal-title":"PLoS One"},{"key":"728_CR45","doi-asserted-by":"crossref","first-page":"723184","DOI":"10.1155\/2011\/723184","volume":"2011","author":"G Gonzalez-Burgos","year":"2011","unstructured":"Gonzalez-Burgos G, Fish KN, Lewis DA (2011) Gaba neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011:723184","journal-title":"Neural Plast"},{"key":"728_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn2044","volume":"8","author":"M Bartos","year":"2007","unstructured":"Bartos M, Vida I, Jonas P (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45\u201356","journal-title":"Nat Rev Neurosci"},{"key":"728_CR47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/schbul\/sbm046","volume":"33","author":"RS Keefe","year":"2007","unstructured":"Keefe RS, Fenton WS (2007) How should dsm-v criteria for schizophrenia include cognitive impairment? Schizophr Bull 33:912\u2013920","journal-title":"Schizophr Bull"},{"key":"728_CR48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mp.2015.113","volume":"20","author":"SA Barnes","year":"2015","unstructured":"Barnes SA, Pinto-Duarte A, Kappe A, Zembrzycki A, Metzler A, Mukamel EA, Lucero J, Wang X, Sejnowski TJ, Markou A, Behrens MM (2015) Disruption of mglur5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders. Mol psychiatry 20:1161\u20131172","journal-title":"Mol psychiatry"},{"key":"728_CR49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00726-006-0319-9","volume":"32","author":"M Pietraszek","year":"2007","unstructured":"Pietraszek M, Nagel J, Gravius A, Schafer D, Danysz W (2007) The role of group i metabotropic glutamate receptors in schizophrenia. Amino Acids 32:173\u2013178","journal-title":"Amino Acids"},{"key":"728_CR50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0893-133X(95)00079-S","volume":"13","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995) Nmda antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13:335\u2013345","journal-title":"Neuropsychopharmacology"},{"key":"728_CR51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","volume":"12","author":"CA Tamminga","year":"1998","unstructured":"Tamminga CA (1998) Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12:21\u201336","journal-title":"Crit Rev Neurobiol"},{"key":"728_CR52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","volume":"98","author":"AR Mohn","year":"1999","unstructured":"Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced nmda receptor expression display behaviors related to schizophrenia. Cell 98:427\u2013436","journal-title":"Cell"},{"key":"728_CR53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","volume":"13","author":"JE Belforte","year":"2010","unstructured":"Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K (2010) Postnatal nmda receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13:76\u201383","journal-title":"Nat Neurosci"},{"key":"728_CR54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00441-006-0275-4","volume":"326","author":"R Sprengel","year":"2006","unstructured":"Sprengel R (2006) Role of ampa receptors in synaptic plasticity. Cell Tissue Res 326:447\u2013455","journal-title":"Cell Tissue Res"},{"key":"728_CR55","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1523\/JNEUROSCI.3503-07.2007","volume":"27","author":"CD Kopec","year":"2007","unstructured":"Kopec CD, Real E, Kessels HW, Malinow R (2007) Glur1 links structural and functional plasticity at excitatory synapses. J Neurosci 27:13706\u201313718","journal-title":"J Neurosci"},{"key":"728_CR56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hipo.22236","volume":"24","author":"D Inta","year":"2014","unstructured":"Inta D, Vogt MA, Elkin H, Weber T, Lima-Ojeda JM, Schneider M, Luoni A, Riva MA, Gertz K, Hellmann-Regen J, Kronenberg G, Meyer-Lindenberg A, Sprengel R, Gass P (2014) Phenotype of mice with inducible ablation of glua1 ampa receptors during late adolescence: relevance for mental disorders. Hippocampus 24:424\u2013435","journal-title":"Hippocampus"},{"key":"728_CR57","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.mp.4002056","volume":"13","author":"LM Wiedholz","year":"2008","unstructured":"Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A (2008) Mice lacking the ampa glur1 receptor exhibit striatal hyperdopaminergia and \u2018schizophrenia-related\u2019 behaviors. Mol psychiatry 13:631\u2013640","journal-title":"Mol psychiatry"},{"key":"728_CR58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0033291711001991","volume":"42","author":"M Bertani","year":"2012","unstructured":"Bertani M, Lasalvia A, Bonetto C, Tosato S, Cristofalo D, Bissoli S, De Santi K, Mazzoncini R, Lazzarotto L, Santi M, Sale A, Scalabrin D, Abate M, Tansella M, Rugger M (2012) The influence of gender on clinical and social characteristics of patients at psychosis onset: a report from the Psychosis Incident Cohort Outcome Study (PICOS). Psychol Med 42:769\u2013780","journal-title":"Psychol Med"},{"key":"728_CR59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2011.02.045","volume":"70","author":"JA Matta","year":"2011","unstructured":"Matta JA, Ashby MC, Sanz-Clemente A, Roche KW, Isaac JT (2011) Mglur5 and nmda receptors drive the experience- and activity-dependent nmda receptor nr2b to nr2a subunit switch. Neuron 70:339\u2013351","journal-title":"Neuron"},{"key":"728_CR60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/schbul\/sbs052","volume":"38","author":"EM Sullivan","year":"2012","unstructured":"Sullivan EM, O\u2019Donnell P (2012) Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophr Bull 38:373\u2013376","journal-title":"Schizophr Bull"},{"key":"728_CR61","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamapsychiatry.2013.1195","volume":"70","author":"AE Timms","year":"2013","unstructured":"Timms AE, Dorschner MO, Wechsler J, Choi KY, Kirkwood R, Girirajan S, Baker C, Eichler EE, Korvatska O, Roche KW, Horwitz MS, Tsuang DW (2013) Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry 70:582\u2013590","journal-title":"JAMA Psychiatry"},{"key":"728_CR62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-015-1411-6","volume":"30","author":"N Matosin","year":"2015","unstructured":"Matosin N, Fernandez-Enright F, Fung SJ, Lum JS, Engel M, Andrews JL, Huang XF, Weickert CS, Newell KA (2015) Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation. Acta Neuropathol 30:119\u2013129","journal-title":"Acta Neuropathol"},{"key":"728_CR63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570159X12666140324183406","volume":"12","author":"F Iasevoli","year":"2014","unstructured":"Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A (2014) The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Curr Neuropharmacol 12:219\u2013238","journal-title":"Curr Neuropharmacol"},{"key":"728_CR64","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1073\/pnas.97.7.3596","volume":"97","author":"RA Garcia","year":"2000","unstructured":"Garcia RA, Vasudevan K, Buonanno A (2000) The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA 97:3596\u20133601","journal-title":"Proc Natl Acad Sci USA"},{"key":"728_CR65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nm1418","volume":"12","author":"CG Hahn","year":"2006","unstructured":"Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12:824\u2013828","journal-title":"Nat Med"},{"key":"728_CR66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","volume":"30","author":"PJ Conn","year":"2009","unstructured":"Conn PJ, Lindsley CW, Jones CK (2009) Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci 30:25\u201331","journal-title":"Trends Pharmacol Sci"},{"key":"728_CR67","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/npp.2016.2","volume":"41","author":"DT Balu","year":"2016","unstructured":"Balu DT, Li Y, Takagi S, Presti KT, Ramikie TS, Rook JM, Jones CK, Lindsley CW, Conn PJ, Bolshakov VY, Coyle JT (2016) An mglu5-positive allosteric modulator rescues the neuroplasticity deficits in a genetic model of nmda receptor hypofunction in schizophrenia. Neuropsychopharmacology 41:2052\u20132061","journal-title":"Neuropsychopharmacology"},{"key":"728_CR68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbr.2012.11.042","volume":"241","author":"D Inta","year":"2013","unstructured":"Inta D, Vogt MA, Luoni A, Filipovic D, Lima-Ojeda JM, Pfeiffer N, Gasparini F, Riva MA, Gass P (2013) Significant increase in anxiety during aging in mglu5 receptor knockout mice. Behav Brain Res 241:27\u201331","journal-title":"Behav Brain Res"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-016-0728-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0728-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:56:22Z","timestamp":1657198582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-016-0728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s00406-016-0728-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}